AMATO, Marco Calogero
 Distribuzione geografica
Continente #
NA - Nord America 8.734
EU - Europa 4.797
AS - Asia 3.478
SA - Sud America 562
AF - Africa 146
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.728
Nazione #
US - Stati Uniti d'America 8.637
SG - Singapore 1.272
CN - Cina 1.223
IT - Italia 977
FI - Finlandia 952
RU - Federazione Russa 563
UA - Ucraina 532
BR - Brasile 468
DE - Germania 466
HK - Hong Kong 352
IE - Irlanda 334
PL - Polonia 305
VN - Vietnam 211
GB - Regno Unito 210
FR - Francia 115
SE - Svezia 113
IN - India 76
TR - Turchia 71
BE - Belgio 55
CI - Costa d'Avorio 55
RO - Romania 55
MX - Messico 46
KR - Corea 36
IQ - Iraq 35
CA - Canada 31
BD - Bangladesh 30
AR - Argentina 29
JP - Giappone 24
ZA - Sudafrica 23
AT - Austria 21
MA - Marocco 20
KE - Kenya 19
NL - Olanda 19
ES - Italia 17
EC - Ecuador 16
CZ - Repubblica Ceca 15
UZ - Uzbekistan 15
IR - Iran 14
CH - Svizzera 12
VE - Venezuela 12
ID - Indonesia 11
EG - Egitto 10
GR - Grecia 10
JO - Giordania 10
AE - Emirati Arabi Uniti 9
CO - Colombia 9
AL - Albania 8
PY - Paraguay 8
SA - Arabia Saudita 8
CL - Cile 7
LB - Libano 7
PE - Perù 7
TW - Taiwan 7
AZ - Azerbaigian 6
BH - Bahrain 6
DZ - Algeria 6
HN - Honduras 6
LT - Lituania 6
NP - Nepal 6
PK - Pakistan 6
KZ - Kazakistan 5
MY - Malesia 5
UY - Uruguay 5
AU - Australia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
EU - Europa 4
IL - Israele 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
BG - Bulgaria 3
KG - Kirghizistan 3
OM - Oman 3
TN - Tunisia 3
AM - Armenia 2
CY - Cipro 2
DK - Danimarca 2
GE - Georgia 2
JM - Giamaica 2
MK - Macedonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RS - Serbia 2
TH - Thailandia 2
TZ - Tanzania 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
KH - Cambogia 1
KW - Kuwait 1
LY - Libia 1
MN - Mongolia 1
NG - Nigeria 1
QA - Qatar 1
Totale 17.722
Città #
Ashburn 1.026
Fairfield 923
Singapore 730
Chandler 605
Woodbridge 485
Wilmington 482
Ann Arbor 458
Houston 425
Seattle 373
Hong Kong 347
Dublin 334
Jacksonville 334
Cambridge 317
Zgierz 270
Medford 213
Palermo 195
Moscow 177
Beijing 171
Des Moines 160
Nanjing 159
Helsinki 153
Princeton 136
Council Bluffs 132
Boardman 109
Munich 107
New York 103
Los Angeles 99
Dearborn 94
Dallas 90
Tulsa 84
Altamura 82
The Dalles 82
Ho Chi Minh City 81
Shenyang 71
Jinan 66
San Diego 65
Changsha 60
Tianjin 57
Nanchang 56
Abidjan 55
Brussels 55
Hanoi 53
Lawrence 53
Milan 47
Izmir 44
Hebei 41
Phoenix 41
São Paulo 41
Zhengzhou 38
Buffalo 37
Ningbo 36
London 35
Santa Clara 35
Guangzhou 31
Jiaxing 31
Chicago 28
Atlanta 27
Kumar 27
Auburn Hills 26
Frankfurt 26
Falls Church 25
Hangzhou 25
Taizhou 24
Saint Petersburg 23
Verona 23
San Jose 22
Seongnam 21
Tokyo 21
Hefei 20
Nuremberg 20
Venice 20
Taiyuan 18
Orem 17
Warsaw 17
Baghdad 16
Frankfurt am Main 16
Nairobi 16
Boston 14
Bucheon-si 14
Da Nang 14
Rio de Janeiro 14
San Paolo di Civitate 14
Lanzhou 13
Rome 13
Stockholm 13
Brno 12
Haikou 12
Denver 11
Düsseldorf 11
Johannesburg 11
Kunming 11
Poplar 11
Amman 10
Ankara 10
Brooklyn 10
Columbus 10
Durham 10
Manchester 10
Mexico City 10
Montreal 10
Totale 11.330
Nome #
BRAFV600E mutation, TIMP-1 up-regulation and NF-{kappa}B activation: closing the loop on the papillary thyroid cancer trilogy. 271
Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory 268
Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. 263
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction 257
In vitro identification and characterization of CD133pos cancer stem-like cells in anaplastic thyroid carcinoma cell lines 247
Anaplastic Thyroid Carcinoma: A ceRNA Analysis Pointed to a Crosstalk between SOX2, TP53, and microRNA Biogenesis. 242
Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index 234
Oligomenorrhea in PCOS is characterized by a high visceral adiposity index (VAI): a likely condition of cardiometabolic risk. 226
Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency 220
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease 220
Fine-Needle Aspiration (FNAB) Molecular Analysis for the Diagnosis of Papillary Thyroid Carcinoma through BRAFv600E mutation and RET/PTC rearrangement 213
Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study 213
The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome 210
BRAFV600E Mutation and p27kip1 Expression in Papillary Carcinomas of the Thyroid ≤1 cm and Their Paired Lymph Node Metastases 206
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome 205
Development of a fuzzy expert system for the control of glycemia in type 1 diabetic patients 200
Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. 199
Visceral Adiposity Index (VAI) Is Predictive of an Altered Adipokine Profile in Patients with Type 2 Diabetes 193
Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome 189
Serum miRNAs in women affected by hyperandrogenic polycystic ovary syndrome: the potential role of miR-155 as a biomarker for monitoring the estroprogestinic treatment 188
Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: efficacy of octreotide therapy 187
OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes. 185
Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein. 184
Use of Glargine in Pregnant Women with Type 1 Diabetes Mellitus: A Case-Control Study 182
Visceral Adiposity Index Is Associated with Insulin Sensitivity and Adipocytokine Levels in Newly Diagnosed Acromegalic Patients. 177
Cornea in acromegalic patients as a possible target of growth hormone action. 175
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. 175
The Metabolic Profile in Active Acromegaly is Gender-Specific. 171
Clamp euglicemico iperinsulinemico e test al glucagone come utili strumenti di valutazione degli effetti metabolici della terapia sostitutiva con GH. 171
Il c-peptide come marker principale nella storia naturale del Diabete tipo 1: ruolo della funzione b-cellulare pancreatica nelle complicanze 170
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? 170
Relative Hypoleptinemia in poor controlled patients with Type 1 Diabetes 170
Body composition assessment for the definition of cardiometabolic risk. 170
Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. 170
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. 169
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment. 169
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 169
Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome. 159
Clinical indications and proper use of Visceral Adiposity Index. 159
Correlation between Severity of Growth Hormone Deficiency and Thyroid Metabolism and Effects of Long-Term Growth Hormone Treatment on Thyroid Function in Children with Idiopathic Growth Hormone Deficiency. 157
Phenotyping of type 2 diabetes mellitus at onset on the basis of fasting incretin tone: Results of a two-step cluster analysis 154
Espressione dei fattori di trascrizione di staminalità in cellule stromali (HASC) ottenute da tessuto adiposo viscerale e sottocutaneo 151
Changes in lipid profile and adipokine levels in GH deficient children during GH replacement therapy. 148
BRAFV600E mutation and timp-1 hyper-expression in classical variants of papillary thyroid carcinoma (PTC). 147
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus. 146
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. 145
Valutazione dell'insulinoresistenza tramite un test pasto standard 144
BRAFV660E mutation and Timp-1 hyper-expression in classical variants of papyllary thyroid carcinoma. 143
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni controregolatori: ruolo del GH 142
Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA). 142
THE CLINICAL ACTIVITY SCORE IN MANAGEMENT OF GRAVES’ OPHTHALMOPATHY: CORRELATION WITH ORBITAL MR IMAGING. 139
Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations 138
GH-suppression test in acromegaly: comparison between OGTT and chocolate test 137
Adrenal incidentaloma: a new contributing factor in metabolic syndrome 136
Safety of glargine therapy during pregnancy in women with type 1 diabetes mellitus. 135
Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency 135
No effect of GH/IGF-1 excess on adrenal glands in acromegalic patients 133
Visceral Adiposity Index (VAI): A Reliable Indicator Of Visceral Fat Function Associated With Cardiometabolic Risk. 133
Endocrine and pro-inflammatory activity of visceral (VAT) and subcutaneous (SAT) adipose tissue in morbidly obese patients with and without metabolic syndrome. 132
Variabili cliniche nella casistica del policlinico di Palermo nell’ambito del registro dei tumori della tiroide in Sicilia: Età, sesso, autoimmunità, tipo, dimensionilesionali e coinvolgimento delle stazioni linfonodali della tiroide 130
Leptina e adiponectina nella valutazione del compenso glicometabolico in corso di diabete mellito di tipo 1 normopeso. 130
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni contro regolatori. 130
Sviluppo di un sistema di supporto decisionale tipo Fuzzy per il controllo della glicemia post-prandiale nel diabete mellito tipo 1 129
Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment 128
Detection of BRAFv600E mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specimens. 127
The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk. 127
Rotterdam consensus, NIH and EAS: comparison among the three different diagnostic criteria for the diagnosis of PCOS. 126
L’uso del hrTSH nel follow up del microcarcinoma tiroideo in pazienti sottoposti a tiroidectomia totale 126
Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia. 126
Detection of BRAFV600 mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specimens 125
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. 123
Visceral Adiposity Index (VAI) as a simple indicator of “adipose tissue dysfunction” in patients with type 2 diabetes. 123
Buon compenso glicemico nei pazienti acromegalici affetti da diabete secondario. 121
Effetti della terapia combinata (OHA+Insulina) su una casistica ambulatoriale di pazienti affetti da NIDDM. 120
Off-line control of the postprandial glycemia in type 1 diabetes patients by a fuzzy logic decision support 120
Alte dosi di cabergolina migliorano i parametri metabolici in pazienti affetti da prolattinoma. 118
Adrenal incidentaloma: a new contributing factor in metabolic syndrome? 117
Alta prevalenza di Sindrome dell’ovaio policistico in donne diabetiche di tipo 1 in età fertile. 115
AlKam Metabolic Syndrome Study (AlkaMeSy Study): Studio di prevalenza sulla sindrome metabolica. 115
Effetti di una terapia con glucocorticoidi ev ad alte dosi sull'oftalmopatia di Graves moderata-severa:uno studio caso-controllo 115
The use of rh-TSH in the follow-up of thyroid microcarcinoma after total thyroidectomy 113
Insulin resistance and polycystic ovary syndrome. 113
Utilizzo del Visceral Adiposity Index per l’identificazione di donne con sindrome iperandrogenica a rischio cardiometabolico. 113
HYPERINSULINISM AND POLYCYSTIC OVARY SYNDROME (PCOS): ROLE OF INSULIN CLEARANCE. 113
The current version of the visceral adiposity index is not suitable for application in pediatric populations: comments on the article by Al-Daghri et al. 112
Prevalenza del cancro del colon e di altre neoplasie in una casistica ambulatoriale di soggetti affetti da diabete mellito tipo 2. 112
Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome 112
Neck liymph nodes in chronic autoimmune thyroiditis: the sonographic pattern. 111
Complete biochemical control and oituitary adenoma disappearance in a child with gigantism: efficay of octreotide therapy 110
Visceral Adipose function, insulin sensitivity and secretion in active acromegaly. 110
Low hrTSH-Tg levels in patients affected by papillary thyroid microcarcinoma are influenced by pre-surgery L-thyroxine therapy. 108
The adipose visceral dysfunction plays an important role in diabetes in Cushing disease. 106
null 104
Low Estradiol-to-Testosterone ratio is associated with low progesterone levels and atherogenic lipidic pattern in women with policystic ovary syndrome (PCOS). 103
The sonographic pattern of neck lymph nodes in chronic autoimmune thyroiditis. 101
Use of antiepileptic drugs in women with polycystic ovary syndrome 97
Increased central corneal thickness in acromegalic patients. 97
Use of basal insulin analog detemir in pregnant women with type 1 diabetes: a case-control retrospective study 97
Marcatori di rischio diabetologico nella Sindrome dell’ovaio policistico (PCOS). 97
PTC REFRACTORY TO RADIOIODINE: A CROSS-SECTIONAL STUDY 97
Totale 15.300
Categoria #
all - tutte 62.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021847 0 0 0 0 0 0 163 72 234 63 152 163
2021/20221.492 42 325 35 48 87 63 64 67 151 197 109 304
2022/20231.854 234 265 35 179 233 304 133 130 224 15 77 25
2023/2024707 42 155 45 53 44 173 40 57 3 8 10 77
2024/20252.251 76 102 154 216 67 84 144 233 159 214 314 488
2025/20263.691 526 204 370 524 718 1.276 73 0 0 0 0 0
Totale 18.295